Marketing-authorisation holder
FGK Representative Service GmbH
10 medicines in 3 countries, as authorisation holder.
Group structure
Part of
FGKPharmaceutical groupOther companies in the group
Headquarters not stated1
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
10 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AVZIVIConcentrato per soluzione per infusione | Bevacizumab | Italy | Authorised | |
| Avzivi | Bevacizumab | EU (EMA) | Authorised | 2024 |
| Avzivi 25 mg/ml concentraat voor oplossing voor infusieConcentraat voor oplossing voor injectie | Bevacizumab | Netherlands | Authorised | 2024 |
| Atropine sulfate FGK | Atropine | EU (EMA) | Refused | |
| Corluxin | Mifepristone | EU (EMA) | Refused | |
| Livmarli | Maralixibat chloride | EU (EMA) | Refused | |
| Memantine FGK | Memantine | EU (EMA) | Refused | |
| Raligize | EU (EMA) | Refused | ||
| Sildenafil FGK | Sildenafil | EU (EMA) | Refused | |
| Zalviso | Sufentanil | EU (EMA) | Withdrawn | 2015 |